The Team
At EntoZyme, we’re working with the genetics of flies and insects and their voracious appetite for waste.
-
Dr Amy Choi
CEO
Dr Amy Choi is a senior executive with over 25 years of extensive experience in the Life Sciences industry, having worked across Pharmaceutical, Medical devices, MedTech and Biotech sectors with expertise and focus on successful commercialisation of over 10 product platforms as well as whole-of-business launch experience in ANZ and key markets including APAC, EU and US with cumulative networth of over $300m. A qualified Pharmacist, she has previously worked for GSK, CSL, Hospira and was the Head of Commercial Operations for Mallinckrodt Pharmaceuticals and Executive GM for Extras Bioscience (an ex-Johnson & Johnson company). More recently, she was the Group CEO for the Personalised Medical devices company, 3DMEDiTech Pty Ltd owned by BRC Capital.
With over a decade of senior leadership experience in early-to-mid start-up companies, particularly in PE-backed private entities; Amy has deep knowledge and operational experience in rapidly translating concepts to revenue and profit generation. She has a proven track record of successfully leading business turnarounds as well as driving expedited growth for start-ups, including securing multi-million dollars strategic partnership deals and contracts.
-
Dr Owain Edwards
CSO
25+ years’ experience developing and commercialising insect-based technologies
-
Dr Maciej Maselko
FOUNDER / DIRECTOR
World-leading animal synthetic biologist based at Macquarie University, co-founder & CTO of NovoClade
-
Evan Hayes
FOUNDER / CHAIR
Highly experienced Executive in Australia and overseas, with expertise in health products and startups
-
Dr Chandran Pfitzner
FOUNDER / SCIENTIST
Inventor of BSF genetic modification technologies
-
Dr Kate Tepper
FOUNDER / SCIENTIST
Developer of enhanced BSF strains
-
Dr Binh Nguyen
SENIOR SCIENTIST
Insect Molecular Biology and Transgenesis
-
Lauren Carey
SENIOR TECHNICIAN
Insect Molecular Biology and Transgenesis